Overview

CJC-1295 with DAC is a modified growth hormone–releasing hormone (GHRH) analog studied for its extended receptor-binding properties in endocrine research models. In laboratory settings, researchers examine its prolonged interaction with pituitary signaling pathways, hormone cascade systems, and IGF-related biochemical frameworks. The DAC modification allows for sustained receptor engagement analysis in controlled experimental environments. CJC-DAC is intended exclusively for laboratory research and analytical use.   Reconstitution & Handling Option: For laboratory convenience, an optional sterile reconstitution service is available. When selected, compounds are prepared under controlled laboratory handling conditions and supplied in research-format delivery systems. An insulated temperature-support pouch is available to assist with transport stability during shipping and storage in research environments. For laboratory research use only.